Recent PTAB victories include:
- Successfully prevented institution of IPR on client's patent directed to certain deuterated drug compounds.
- Achieved victory for IPR petitioner on patent to a method of using an anti-cancer biologic. The decision helps clear our client's path to launching a biosimilar.
- Achieved victory for patent owner in IPRs involving patents on a novel drug dosing regimen. The decisions help protect our client's innovative drug.
- Achieved victory for IPR petitioner on patents to methods of using a nitrogen-scavenging drug. The decisions help clear our client's path to launching a generic drug.
Significant Hatch-Waxman and other litigation victories include:
- Invalidated five patents involved in an ANDA bench trial relating to an extended release ADHD suspension. The decision helps clear our client's path to launching its generic drug.
- Represented a pharmaceutical company against a multi-billion dollar damages claim in a jury trial concerning an epilepsy drug. Case settled during trial, resulting in a favorable settlement.
- Invalidated five patents involved in an ANDA bench trial for a client sued for infringing patents for treatment of overactive bladder. The Federal Circuit affirmed.
- Defended a specialty supplements company concerning their krill oil products before the ITC, in a case that extended to the PTAB. A favorable settlement was reached.
- Obtained a $5.7M award at summary judgment for a nutritional supplements company in a trademark and copyright counterfeiting case.
- Represented a patent licensee in a patent infringement suit concerning mobile video technology used by spectators at sporting events.
- Represented a respondent in an ITC patent infringement trial concerning patents covering video analytics technology.
- Represented a pharmaceutical company in an action involving patents for an extended release formulation of an antibiotic. Helped overturn a preliminary injunction, allowing client to market its generic equivalent of the drug.
Ms. Hardman is a contributor to the firm’s Biosimilars Reference Guide, Guide to the Biosimilars Patent Dance, and Big Molecule Watch blog.
She is a member of the Patent Trial and Appeal Board Bar Association and the William C. Conner Inn of Court.
Ms. Hardman’s recent pro bono work includes assisting a student in obtaining special education services.
Prior to joining Goodwin in 2014, Ms. Hardman was a partner at Kenyon & Kenyon LLP in New York City, where her practice focused on patent litigation and counseling matters.